⚠️WEAR MASK EVEN IF VACCINATED—Top @WHO leader urges masks against #DeltaVariant even if 2-dose vaxxed. "Vaccine alone won't stop community transmission. People need to use masks consistently, be in ventilated spaces—even if you're vaccinated" #COVID19🧵
https://t.co/qPZTmcy9iW
The heroic work of @mitragltm, with support of our fantastic colleagues and collaborators, is finally out!! Demonstrating that there is a lot of potential to reduce and refine animal experimentation.
https://t.co/CwfLStMVkL
#3Rs#SARSCoV2@unibern@3RCC@CDCgov@snsf_ch@HonoursI
While single-dose #COVID19 vaccines are preferred, two-dose may improve efficacy. Solforosi, Kuipers, Zahn et al. @JanssenGlobal show that immunogenicity of Ad26.COV2.S is improved in nonhuman primates after a second dose. https://t.co/WUImQA8YNK
#Infectiousdisease#hostdefense
It has been for a while in the "limbo" but finally got published in Nature! It has been a great collaboration Dave @DewIvcp, Charaf @CharafBenarafa, and Martin @Loeffler_News ...
SARS-CoV-2 spike D614G change enhances replication and transmission
https://t.co/VuhR8wkVz6
Lewy bodies are normally linked to the development of Parkinson’s disease.
We observed these α-synuclein deposits in the brains of #SARS_CoV_2 infected macaques.
https://t.co/yirceQQxVj
Belangrijke nieuwe inzichten in wat misloopt in het afweersysteem van mensen met ernstige COVID.
Proficiat @ewauters Joost Wauters @LambrechtsDlab @PierreVM0 @JunbinQian @NeytsVirology en vele anderen. Dank voor de fijne samenwerking. https://t.co/f6H3q7yyxv
In our @PLOSPathogens review we (ESRs from @HonoursI) give an accessible overview of the research and development challenges commonly faced upon the emergence of a novel pathogen, using as example the current #SARSCoV2 outbreak response.
Check it out!👉https://t.co/orNyW9FlVO
Interested in a collaborative PhD between the @KU_Leuven and @GSK on the "The Human Virome in Respiratory and Skin Disorders"? Check out our latest PhD-vacancy: https://t.co/IoAVV6mmuP. Please ReTweet.
Our ESRs work on viruses crossing borders between humans and animals has been published in several peer-reviewed international journals.
From hard core fundamental science to sophisticated assays for detection...check the publications tab in our webpage! 👉🏼https://t.co/El2D7UvcbT
Three new virus families found to target human parasites! New HONOURs study out today in @NatureComms from @Kinsella_Cormac, @hoekepoek, @mlcotten13 and collaborators @amsterdamumc. https://t.co/i5PqPhTCSB
Protective immunity against seasonal #coronaviruses is short-lived, likely also for #SARSCoV2, published today in @NatureMedicine. Very proud to be part of this amazing team and contribute to the fight against #COVID19. https://t.co/Ef5sNcCbop
The INgezim COVID assays use the SARS-CoV-2 nucleoprotein (N protein) as the antigen for the detection of antibodies to SARS-CoV-2. A quick test developed at @ingenasa
https://t.co/yPpZCD4sjF
Happy to see our work published at @PLOSNTDs! We describe an Affimer that inhibits CCHFV NP function and its application in diagnostic assays (ELISA & LFA).
Made possible thanks to @BarrLeeds, @Tomlinson_lab, @avacta, @ingenasa & @MSCActions (@HonoursI)
https://t.co/Y8V7bv9U65